×

Biotech and Pharmaceuticals Pharmaceuticals

  • Aspen, a drugmaker with operations in 50 countries, has looked to injectibles such as anesthetics to increase sales, building up its business in the past year with the commercial rights to AstraZeneca drugs and products from GlaxoSmithKline. The deal with AstraZeneca covers the intellectual property and manufacturing rights to a portfolio of anesthetics a...

  • Aspen, a drugmaker with operations in 50 countries, has looked to anaesthetics to increase sales, building up its business in the past year with the commercial rights to AstraZeneca drugs and products from GlaxoSmithKline. The deal with AstraZeneca covers the U.S. rights to a portfolio of anaesthetics a year after Aspen bought the rights in other parts of the...

  • Sept 13- A U.S. judge on Wednesday ordered Martin Shkreli to be jailed while he awaits sentencing for securities fraud, citing a Facebook post in which the former drug company executive offered a $5,000 reward for a strand of Hillary Clinton's hair. He had been free on a $5 million bail since his December 2015 arrest. District Judge Kiyo Matsumoto ruled that...

  • Ex-pharmaceutical executive Martin Shkreli leaves after his appearance at the U.S. District Court for the Eastern District of New York on the first day of his securities fraud trial on June 26, 2017 in the Brooklyn borough of New York City.

    Prosecutors said Shkreli is a "danger to the community" because of alleged threats he made against Clinton and other women online.

  • Sept 13- A U.S. judge on Wednesday ordered Martin Shkreli to be jailed while he awaits sentencing for securities fraud, citing a Facebook post in which the former drug company offered a $5,000 reward for a strand of Hillary Clinton's hair. Shkreli, who had been free on $5 million bail since his December 2015 arrest, was silent and stony-faced as U.S. marshals led out...

  • Sept 13- A U.S. judge on Wednesday ordered Martin Shkreli to be jailed while he awaits sentencing for securities fraud, citing a Facebook post in which the former drug company executive nicknamed the "Pharma Bro" offered a $5,000 reward for a strand of Hillary Clinton's hair. District Judge Kiyo Matsumoto in Brooklyn said the Sept. 4 post, which prompted a call from...

  • Sept 13- A U.S. judge on Wednesday ordered Martin Shkreli to be jailed while he awaits sentencing for securities fraud, citing a Facebook post in which the former drug company executive nicknamed the "Pharma Bro" offered a $5,000 reward for a strand of Hillary Clinton's hair. District Judge Kiyo Matsumoto in Brooklyn said the Sept. 4 post, which prompted a call from...

  • Former pharmaceutical executive Martin Shkreli and attorney Benjamin Brafman depart the U.S. District Court for the Eastern District of New York, August 3, 2017 in the Brooklyn borough of New York City.

    Prosecutors say Shkreli is a "danger to the community" because of alleged threats he made against Clinton and other women online.

  • Martin Shkreli apologizes for bizarre Facebook post offering cash for Hillary Clinton's hair

    Martin Shkreli apologized for a bizarre Facebook post about Hillary Clinton's hair that threatens to land him in jail.

  • Former drug company executive Martin Shkreli stands with his attorney Benjamin Brafman after exiting U.S. District Court upon being convicted of securities fraud, in the Brooklyn borough of New York City, U.S., August 4, 2017.

    Martin Shkreli apologized for a bizarre Facebook post about Hillary Clinton's hair that threatens to land him in jail.

  • Sept 12- Former drug company executive Martin Shkreli on Tuesday apologized for a Facebook post that offered his followers a $5,000 reward for obtaining a strand of Hillary Clinton's hair, a post that led U.S. prosecutors to ask that he be jailed while he awaits sentencing for securities fraud. District Judge Kiyo Matsumoto, Shkreli, 34, said he did not mean to...

  • NEW YORK, Sept 12- Generic drugmaker Mylan NV alleged in a court filing that rival Allergan Plc is trying to take advantage of Native American sovereignty to shield its patent for the blockbuster dry-eye treatment Restasis. In Federal District Court in Marshall, Texas, on Monday, Mylan said Allergan is "attempting to misuse Native American sovereignty to shield...

  • *To shift headquarters to Boston, close some sites. The company named longtime Biogen Inc finance chief Paul Clancy as CFO in June, months after appointing former Baxalta executive Ludwig Hantson as CEO. Alexion's restructuring efforts showed the drugmaker was focused on execution and serious about controlling costs, Cowen& Co analyst Eric Schmidt said.

  • The drugmaker also said it would relocate its headquarters to Boston from New Haven, Connecticut by mid-2018. Alexion named long-time Biogen Inc finance chief Paul Clancy as CFO in June, as newly appointed Alexion CEO Ludwig Hantson stepped up efforts to regain investor confidence. It expects pre-tax expenses of $340 million to $440 million related to the...

  • Sept 12- U.S. drugmaker Alexion Pharmaceuticals Inc said on Tuesday it would lay off about 20 percent of its global workforce in an effort to cut spending. The company had about 3,100 full-time employees worldwide as of the end of last year. Alexion also said it would relocate its headquarters to Boston from New Haven, Connecticut by mid-2018.

  • Sept 12- A groundbreaking deal between Allergan Plc and a Native American tribe to shield the company's patents in administrative proceedings could also be used be to protect them from challenges in federal court, legal experts said, potentially dealing a blow to generic competition. Allergan said on Friday it had transferred patents on its blockbuster dry...

  • Cramer's lightning round: Allergan's in a torturous situation

    Jim Cramer rattles off his take on callers' favorite stocks, including one hurting pharmaceutical name.

  • CNBC Mad Money Lightning Round

    Jim Cramer rattles off his take on callers' favorite stocks, including one hurting pharmaceutical name.

  • Sept 11- A groundbreaking deal between Allergan Plc and a Native American tribe to shield the company's patents in administrative proceedings could also be used be to protect them from challenges in federal court, legal experts said, potentially dealing a blow to generic competition. Allergan said on Friday it had transferred patents on its blockbuster dry...

  • Sept 11- Teva Pharmaceutical Industries, on Monday agreed to sell its contraceptive brand Paragard to a unit of Cooper Cos for $1.1 billion, on a day the struggling Israeli drugmaker named industry veteran Kare Schultz as CEO. "Investors will like this news, as in addition to a good price for the asset, and the recent share decline has been likely due in part to...